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As one of the major pathogens in wound infections, Pseudomonas aeruginosa produces
several virulence factors and forms biofilms; these processes are under the regulation of
various quorum sensing (QS) systems. Therefore, QS has been regarded as a promising
target to treat P. aeruginosa infections. In the present study, we evaluated the effect
of the plant-derived QS inhibitor coumarin on P. aeruginosa biofilms and virulence.
Coumarin inhibited QS in the P. aeruginosa QSIS2 biosensor strain, reduced protease
and pyocyanin production, and inhibited biofilm formation in microtiter plates in different
P. aeruginosa strains. The effects of coumarin in inhibiting biofilm formation in an in vitro
wound model and reducing P. aeruginosa virulence in the Lucilia sericata infection model
were strain-dependent. Transcriptome analysis revealed that several key genes involved
in the las, rhl, Pseudomonas quinolone signal (PQS), and integrated QS (IQS) systems
were downregulated in coumarin-treated biofilms of P. aeruginosa PAO1. Coumarin also
changed the expression of genes related to type III secretion and cyclic diguanylate (c-di-
GMP) metabolism. The cellular c-di-GMP level of P. aeruginosa PAO1 and recent clinical
P. aeruginosa strains was significantly reduced by coumarin. These results provide new
evidence for the possible application of coumarin as an anti-biofilm and anti-virulence
agent against P. aeruginosa in wound infections.
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INTRODUCTION
The opportunistic pathogen Pseudomonas aeruginosa frequently causes diverse infections in
immunocompromised patients (Lyczak et al., 2000; Obritsch et al., 2005; Gellatly and Hancock,
2013), and is involved in both acute and chronic wound infections associated with high morbidity
and mortality. Chronic wounds such as diabetic ulcers, venous ulcers, and pressure ulcers affect
millions of patients worldwide and lead to high costs for the healthcare system (e.g., they represent
an estimated cost of around 25 billion per year in the United States alone) (Sen et al., 2009).
Infections in burn wounds also pose a heavy medical and economic burden in both developed and
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developing countries (McManus et al., 1985; Holder, 1993).
Wound infections with P. aeruginosa are especially difficult to
treat and are often associated with worse outcomes compared to
other pathogens (Ünal et al., 2005), due to the extensive arsenal
of virulence factors and increasing antibiotic resistance (Hirsch
and Tam, 2010; Strateva and Mitov, 2011). In addition, biofilms
formed by P. aeruginosa in wound infections further protect the
bacteria from host immune defense and antimicrobials, impeding
the healing process and triggering the shift to chronic wounds
(Rybtke et al., 2011; Mulcahy et al., 2014). Therefore, there is an
urgent need to develop alternative strategies to combat biofilm-
related P. aeruginosa infections.
Quorum sensing (QS) is the intercellular communication
process based on the production and detection of, and group-
level response to, signal molecules (Waters and Bassler, 2005).
The complex P. aeruginosa QS network has intensively been
studied in the past decades as QS plays a crucial role in
coordinating the production of several important virulence
factors, including pyocyanin, protease, exotoxin A, hydrogen
cyanide, and rhamnolipid (Smith and Iglewski, 2003). QS
also affects biofilm formation and antibiotic resistance through
multiple distinct mechanisms (Shih and Huang, 2002; Bjarnsholt
et al., 2005; De Kievit, 2009; Rasamiravaka and El Jaziri,
2016). So far, four interacting QS systems have been identified
in P. aeruginosa, including the N-acyl-homoserine lactone
(AHL)-based rhl and las systems, the Pseudomonas quinolone
signal (PQS) system, and the recently identified integrated QS
(IQS) system (Lee and Zhang, 2015). This QS network allows
P. aeruginosa to secrete extracellular virulence factors only when
they can be produced at a sufficiently high level to overcome the
host defense (Van Delden and Iglewski, 1998). In addition, QS
has been reported to be involved in the spread of P. aeruginosa in
burn wound infections (Rumbaugh et al., 1999).
Quorum sensing inhibition has been proposed as a promising
anti-virulence strategy which would allow to “disarm” pathogens
rather than killing them, and many potential QS inhibitors
(QSIs) have been described (Kalia, 2013; LaSarre and Federle,
2013; Brackman and Coenye, 2015). A wide range of structurally
different QSIs targeting P. aeruginosa have been identified, both
from natural and synthetic sources (Jakobsen et al., 2013). The
first comprehensively studied QSI is the furanone compound C-
30 (Hentzer et al., 2003), which increased P. aeruginosa biofilm
susceptibility to tobramycin and led to more efficient clearance of
bacteria in a pulmonary mouse infection model (Wu et al., 2004).
Ajoene, a sulfur-rich molecule from garlic, reduces expression
of several QS-regulated virulence factors by activating the QS
negative regulator RsmA through two small regulatory RNAs,
RsmY, and RsmZ (Jakobsen et al., 2012, 2017). Many other QSIs
such as 6-gingerol (Kim et al., 2015) and quercetin (Ouyang et al.,
2016) have also been reported to reduce the virulence and biofilm
formation of P. aeruginosa. These studies together demonstrate
the possibility of using QSIs to control P. aeruginosa infections
in vitro and/or in animal infection models.
Coumarin is a plant-derived phenolic compound and
its derivatives are known for their anti-tumor and anti-
inflammatory activities (Fylaktakidou et al., 2004; Kim et al.,
2015; Reen et al., 2018). Coumarin has been described as an
inhibitor of QS in P. aeruginosa and several other gram-negative
bacteria (Gutiérrez-Barranquero et al., 2015). It was shown to
inhibit biofilm formation, phenazine production, and motility in
P. aeruginosa strain PA14 (Gutiérrez-Barranquero et al., 2015)
and suppress virulence in Vibrio splendidus (Zhang et al., 2017).
However, the mechanism by which coumarin inhibits QS has not
been elucidated yet.
The goal of the present study was to evaluate the potential
role of coumarin in the treatment of P. aeruginosa-infected
wounds. To this end, we determined the effect of coumarin on
the production of virulence factors and biofilm formation in an
in vitro wound model, using the P. aeruginosa reference isolate
PAO1 as well as several P. aeruginosa clinical wound isolates.
We also investigated the effect of coumarin on P. aeruginosa
virulence to Lucilia sericata maggots, which are widely used in
the debridement of chronic wounds (Chambers et al., 2003). The
QS-regulated virulence factors of P. aeruginosa are responsible
for killing of these maggots and often lead to the failure of
maggot therapy in wounds infected with P. aeruginosa (Andersen
et al., 2010). Therefore, we explored the possible use of coumarin
as a pre-treatment to inhibit the QS controlled virulence of
P. aeruginosa and increase the survival of maggots when treating
wound infections heavily colonized with P. aeruginosa. Finally,
transcriptome analysis in both planktonic and biofilm cells was
performed to identify genes involved in the inhibition of QS by
coumarin.
MATERIALS AND METHODS
Bacterial Strains, Chemicals, and Growth
Media
Pseudomonas aeruginosa strains 1803, 2063, 2091, 2549, and
3120 were isolated from wound infections in 2017 and obtained
from the Ghent University Hospital, Belgium. Reference strain
P. aeruginosa PAO1 and these five wound isolates were
routinely cultured in Luria-Bertani (LB) agar or broth (Lab
M limited, United Kingdom) or Tryptic Soy Agar (TSA,
Lab M limited, United Kingdom). The QS inhibition selector
P. aeruginosa QSIS2 (Rasmussen et al., 2005) was cultured in ABT
minimal medium (AB medium, containing 2.5 mg/L thiamine)
supplemented with 0.5% glucose, 0.5% casamino acids, and
80 µg/mL gentamicin. All strains were grown aerobically at
37◦C. Coumarin was purchased from Sigma-Aldrich (Bornem,
Belgium) and dissolved in dimethyl sulfoxide (DMSO) (Alfa
Aesar, Germany) as stock solutions (1 M). L. sericata maggots in
BioBags were purchased from BioMonde (Germany), and were
used immediately after receipt.
QS Inhibition Assay
The P. aeruginosa QSIS2 reporter strain is a lasI rhlI double
mutant containing plasmid pLasB-SacB1 encoding an AHL-
induced killing system (Rasmussen et al., 2005). The QS
inhibition assay based on QSIS2 was performed as previously
described, with minor modifications (Brackman et al., 2009).
Briefly, an overnight culture of QSIS2 was diluted in ABT
medium to an optical density at 590 nm (OD590) of 0.1. Cell
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suspensions (50 µL) and 50 µL LB with sucrose (224 mg/mL)
was added to 96-well microtiter plates, supplemented with
gentamicin at a final concentration of 80 µg/mL. N-(3-
oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) and
N-butyryl-L-homoserine lactone (C4-HSL) (200 nM each,
Sigma) were added to activate the QS system as positive controls,
and sterile MilliQ ultrapure water was used as a negative control.
To test the QS inhibition effect, coumarin was added in a
final concentration of 1, 1.5, 2, 2.5, and 3 mM. The microtiter
plates were incubated for 10 h at 37◦C, and the absorbance was
measured at 450 nm using an EnVision Multilabel Reader (Perkin
Elmer, Waltham, MA, United States). The difference in growth
between the negative control without AHLs and the positive
control with AHLs was considered as 100% QS inhibition. Three
independent experiments were performed with three replicates
each (n = 9).
Measurements of Pyocyanin and
Protease Production
Overnight cultures of P. aeruginosa strains were standardized
to OD590 0.5 and 1:50 diluted in 10 mL LB with or without
coumarin (2 mM). After 24 h incubation at 37◦C, the supernatant
was collected and filter-sterilized. For the pyocyanin assay,
chloroform (3 mL) was added to 5 mL P. aeruginosa culture
supernatant and vortexed. The chloroform phase was kept after
centrifugation (5000 rpm, 5 min), and mixed with 1 mL HCl
(0.2 M). The absorbance of the pink HCl layer was measured
at 520 nm with the EnVision Multilabel Reader after vortexing
and centrifugation (Krishnan et al., 2012). 0.2 M HCl was
used as a negative control in the measurement of absorbance.
Protease production was tested by the azocasein assay as
described previously (Nicodeme et al., 2005; Vandecandelaere
et al., 2014) with modifications. Azocasein (Sigma) solution
(400µL, 5 mg/mL 0.1 M Tris-HCl buffer) was mixed with 400µL
supernatant and incubated at 37◦C for 1 h. The reaction was
stopped by adding 100 µL 10% (w/v) trichloroacetic acid and the
mixture was then centrifuged. 100µL of the resulting supernatant
was transferred to 96-well microtiter plates and mixed with
100µL 625 mM NaOH. The absorbance was measured at 420 nm
with an EnVision Multilabel Reader. Azocasein solution with LB
medium was processed following the same procedure and used
as blank control. Two independent experiments were performed
with three replicates each (n = 6).
The Effect of Coumarin on Planktonic
Cell Growth and on Biofilm Formation in
Microtiter Plates
Overnight cultures of P. aeruginosa strains were standardized to
OD590 0.5 and inoculated in 200 µL of LB with 1:50 dilutions
with or without coumarin in microtiter plates at 37◦C. The
growth of planktonic cells was quantified by measuring the
absorbance at 450 nm (in order to avoid the interference of
pyocyanin) using an EnVision Multilabel Reader (Perkin Elmer,
Waltham, MA, United States). Three independent experiments
were performed (n = 3).
Biofilm formation in microtiter plates was evaluated as
described previously (Brackman et al., 2009). Briefly, overnight
cultures of P. aeruginosa strains were diluted to approximately
5 × 107 CFU/mL in LB broth. 100 µL of the suspension was
transferred to the wells of a round-bottomed 96-well microtiter
plate with coumarin in a final concentration of 1 mM or 2 mM.
10 µL MilliQ with DMSO was added for the control. The plate
was incubated at 37◦C for 4 h, and then the wells were rinsed
once with sterile physiological saline (PS) and re-filled with fresh
medium and coumarin. The plate was incubated at 37◦C for an
additional 20 h. After removing the supernatant and washing the
wells once with sterile PS, two cycles of vortexing (5 min) and
sonication (5 min) were performed to release biofilm cells, and
the number of CFU/biofilm was determined by plating. Three
independent experiments were performed with three replicates
each (n = 9).
The Effect of Coumarin on Biofilm
Formation in a Wound Model
The biofilm wound model used has been described before
(Brackman et al., 2016). A spongy artificial dermis of 1 cm3
(upper layer: chemically cross-linked hyaluronic acid, lower
layer: hyaluronic acid and collagen) is used as a substrate for
biofilm formation to mimic biofilm formation at the air-liquid
interface in real wounds. Each sheet of artificial dermis was
placed in a 24-well microtiter plate. 300 µL medium containing
Bolton Broth, heparinized bovine plasma and freeze-thaw laked
horse blood was added on dermis. Coumarin was added in a
final concentration of 2 mM. P. aeruginosa suspensions (10 µL)
containing approximately 104 bacterial cells were added on top
of the dermis. After 24 h, the infected dermis was washed with
1 mL PS and was transferred into 9 mL PS. Biofilm cells on the
dermis were collected by three cycles of vortexing (30 s) and
sonication (30 s). The number of CFU/dermis was quantified
by plating. Three independent experiments were performed with
three replicates each (n = 9).
The Effect of Coumarin on P. aeruginosa
Virulence to L. sericata
Blood agar (5% horse blood in LB agar) was prepared in 6 cm
Petri dishes with DMSO as control or with coumarin (2 mM
in a final concentration). P. aeruginosa bacteria (5 × 105 CFU)
were spread on the blood agar and incubated overnight at 37◦C
before the assay. The maggots were aseptically transferred onto
the blood agar (10 maggots per plate) and cultured at 37◦C in the
dark (n = 50 in total from two independent experiments). Maggot
survival was assessed after 24 h. Immobile/inactive maggots
were considered to be dead, and maggot death was verified by
stimulating the maggots with an inoculation needle.
RNA Extraction, Sequencing and
Analysis
RNA sequencing was performed on coumarin-treated
(2 mM, 24 h) and untreated P. aeruginosa PAO1 biofilms.
To detect the initial changes on gene expression due to the
coumarin treatment also shortly treated (2 mM, 1 h) and
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untreated planktonic cultures were included. Suspensions
of planktonic cells (5 × 107 CFU/mL) were added to a 96-
well microtiter plate and treated with 2 mM coumarin or
DMSO as control. After incubation at 37◦C for 1 h, cells were
collected on ice for RNA extraction. Biofilms were formed
in microtiter plates with 2 mM coumarin or DMSO and
cells from 24 h-biofilms were collected as described above.
Subsequently, total RNA was extracted immediately using the
Ambion RiboPureTM RNA Purification Kit (Life Technologies,
Renfrewshire, United Kingdom) according to the manufacturer’s
instructions. Three biological replicates were performed for each
condition.
RNA sequencing was performed as described previously
(Van Acker et al., 2014). Total RNA of each sample was
depleted for ribosomal RNA using the Ribo-Zero Magnetic
Kit for gram-negative bacteria (Epicentre, Madison, WI,
United States). Truseq stranded RNA library preparation kit
(Illumina) was then used to create strand-specific cDNA
sequencing libraries. Quality control of the libraries (DNA 1000
chip, Agilent Technologies, Santa Clara, CA, United States) was
performed and the concentration was determined according
to recommendations provided by Illumina. Sequencing was
performed using an Illumina NextSeq 500, generating 75 bp
unpaired reads. Fastq files were deposited at ArrayExpress under
the accession number E-MTAB-6629. Using CLC Biosystems
Genomic Workbench 10.1.1 (CLC Bio, Qiagen, Waltham,
MA, United States), quality trimming was performed and
the quality filtered reads of each sample were mapped
(length fraction 0.8 and similarity fraction 0.8) against the
genome sequence of P. aeruginosa PAO1 (the NCBI reference
sequence with accession number NC_002516). Total gene
read values are used by the differential expression for RNA-
Seq tool based on a negative binomial generalized linear
model (GLM) in CLC Workbench. Only genes that were
significantly differentially regulated (the false discovery rate
adjusted p-value < 0.05) and with at least 1.5-fold change
compared to the control were considered. Gene descriptions were
obtained from the Pseudomonas Genome Database (Winsor et al.,
2015).
C-di-GMP Quantification
Quantifications of cyclic diguanylate (c-di-GMP) levels in
P. aeruginosa cells were performed as described previously
(Burhenne and Kaever, 2013). Briefly, an overnight culture of
P. aeruginosa strains was standardized to OD590 0.5 and 200 µL
was inoculated in 9.8 mL of LB with or without coumarin. After
24 h, the cells were harvested by centrifugation at 4◦C for 20 min
from 5 mL culture suspensions. The wet weight of collected
cells was measured. Cells were lysed in ice-cold extraction
buffer consisting of acetonitrile/methanol/water (2/2/1, v/v/v),
and incubated at 4◦C for 15 min. The cell suspension was then
heated to 95◦C for 10 min and centrifuged. The extraction of
the resulting pellet was repeated twice with 200 µL of extraction
solvent at 4◦C omitting the heating step. The solvent of the
combined supernatants was evaporated to dryness in a vacuum
centrifuge. The pellets were dissolved in HPLC-grade water
for analysis by liquid chromatography-coupled tandem mass
FIGURE 1 | QS inhibition effect of coumarin detected by P. aeruginosa QSIS2
reporter strain. Data shown are the mean (n = 9), error bars represent standard
deviation.∗p < 0.05 compared to negative control in one-way ANOVA.
spectrometry as described before (Burhenne and Kaever, 2013).
Three independent experiments were performed (n = 3).
Statistical Analyses
Numerical data were analyzed using GraphPad Prism 6.0 and
presented as mean ± standard deviation (SD). The normal
distribution of the data was checked by the D’Agostino-Pearson
normality test. Normally distributed data were analyzed by one-
way ANOVA or Student’s t-test, and non-normally distributed
data were analyzed by the Kruskal–Wallis test or the Mann–
Whitney test.
RESULTS
Coumarin Inhibits QS in P. aeruginosa
QSIS2 Biosensor
The previously described QS inhibitory activity of coumarin
was confirmed using the P. aeruginosa QSIS2 reporter strain, in
which the QS inhibition effect was represented by the cell growth
(A450). As shown in Figure 1, while 1 mM coumarin showed no
significant QS inhibition effect, approx. 20∼40% QS inhibition
could clearly be observed at concentrations of 1.5, 2, 2.5, and
3 mM compared with the negative control in which the QS system
was fully activated.
Coumarin Reduces Pyocyanin and
Protease Production in Different
P. aeruginosa Strains
Pyocyanin production was significantly decreased by coumarin
in strains PAO1, 2063, 2091, and 2549 (p < 0.05), but not in
strains 1083 and 3120 which produced virtually no pyocyanin
in the experimental conditions used (Figure 2A). Coumarin also
reduced protease production in P. aeruginosa PAO1 and the
five clinical strains, to varying degrees (p < 0.05) (Figure 2B).
These results indicate that coumarin inhibits the production of
QS-regulated virulence factors in different P. aeruginosa clinical
strains.
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FIGURE 2 | Effect of coumarin (2 mM) on pyocyanin (A) and protease (B) production in different P. aeruginosa strains. Data shown are the mean (n = 6), error bars
represent standard deviation. ∗p < 0.05 compared to the untreated control group in Mann–Whitney test.
FIGURE 3 | The effect of coumarin on P. aeruginosa biofilms. Data shown are
the mean (n = 9), error bars represent standard deviation. (A) Biofilms formed
in microtiter plates. ∗p < 0.05 compared to the untreated control group in
one-way ANOVA or Kruskal–Wallis test. (B) Wound model biofilms treated
with 2 mM coumarin. ∗p < 0.05 compared to the untreated control group in
Student’s t-test or Mann–Whitney test.
The Effect of Coumarin on P. aeruginosa
Biofilms
No significant effect on growth of planktonic cells of
P. aeruginosa strains was observed when 1 mM or 2 mM
coumarin was added (Supplementary Figure S1). The effect
of coumarin on biofilm formation of P. aeruginosa strains was
tested in 96-well microtiter plates as well as in an in vitro wound
model. In microtiter plates, biofilm formation of all P. aeruginosa
strains investigated was significantly reduced in the presence of
2 mM coumarin (p < 0.05) (Figure 3A); for four strains (2063,
2091, 2549, and 3120) this was also the case in the presence of
1 mM coumarin.
In the wound model, statistically significant reduced biofilm
formation in the presence of 2 mM coumarin was observed for
P. aeruginosa PAO1, 2091, and 3210 (p < 0.05) (Figure 3B).
Biofilm formation for the other three clinical strains showed a
non-significant decrease of approx. 30%.
The Effect of Coumarin on P. aeruginosa
Virulence to L. sericata
As shown in Figure 4, the virulence of P. aeruginosa to L. sericata
varied between different clinical isolates. P. aeruginosa 2549
appeared to be most virulent among the strains tested, as
exposure of the larvae to this strain led to>90% killing after 24 h.
In the coumarin-treated groups, significant increase in L. sericata
survival was observed for PAO1 and 1803, with 34% and 54%
more survival compared to the control groups, respectively. For
the other P. aeruginosa strains, coumarin increased the survival
of L. sericata by 6∼16% but this was not significant. It should,
however, be noted that for two of these strains (2091 and 3120)
survival already was quite high in the control group, suggesting
these strains are less virulent in this model.
Transcriptome Analysis of P. aeruginosa
Planktonic and Biofilm Cells Treated
With Coumarin
In order to obtain insight into the mechanism(s) behind the QS
inhibitory effect of coumarin, RNA sequencing was performed
on P. aeruginosa PAO1 planktonic cells after 1 h coumarin
treatment (2 mM) and biofilm cells grown in the presence of
coumarin (2 mM) for 24 h. In planktonic cells, 46 genes were
downregulated and 21 genes were upregulated by coumarin
(Supplementary Table S1). Nearly half of the downregulated
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FIGURE 4 | The effect of coumarin (2 mM) on survival of L. sericata. Data
shown are the mean (n = 9), error bars represent standard deviation.
∗p < 0.05 compared to the untreated control group in Mann–Whitney test.
genes (21) were related to the type III secretion system (T3SS),
including the key genes coding for the needle complex (pscF,
pscJ, and pscL), the translocation apparatus (pcrV, popB, and
popD), the chaperones (pcrH and pscG), as well as the effector
proteins (exoS and exoT). Two sets of two-component regulator
systems were downregulated (PA4774/PA4775 and pmrAB). An
oxidative stress sensing regulator ospR was repressed, as well as
gene PA2826 (encoding a glutathione peroxidase which is under
the regulation of ospR) (Lan et al., 2010). This result indicated
that coumarin might affect the response of P. aeruginosa to
oxidative stress. One HD-GYP domain phosphodiesterase (PDE)
encoding gene (PA4781) was downregulated; PA4781 has been
reported to degrade c-di-GMP (Ryan et al., 2009; Stelitano et al.,
2013; Rinaldo et al., 2015). However, no significant changes
in either QS or QS-regulated virulence genes were observed
in coumarin-treated planktonic samples, except that phzG2
involved in phenazine production was repressed by over 50-fold.
In coumarin-treated biofilms, 399 genes were significantly
downregulated (Supplementary Table S2). Among them, several
core genes involved in the four different QS systems of
P. aeruginosa were repressed. The AHL synthase encoding genes
lasI and rhlI were both downregulated, as was the receptor
encoding gene rhlR. The expression of lasR was not significantly
influenced. Gene pqsB and pqsC within the pqsABCDE operon
(which controls PQS synthesis) were both downregulated, as was
pqsH (involved in the conversion of 2-heptyl-4-quinolone to
PQS). No difference was observed in the expression of the gene
encoding the PQS receptor PqsR. Moreover, genes responsible
for the synthesis of IQS (ambBCDE) were also significantly
downregulated in coumarin-treated biofilms. In addition, genes
involved in the production of QS-regulated virulence factors
including alkaline protease, hydrogen cyanide, LasA protease,
LasB elastase, phenazine, siderophores, and rhamnolipids were
significantly downregulated. These results confirm that coumarin
interferes with the QS network of P. aeruginosa and the
production of QS-related virulence factors. Genes involved
in T3SS were repressed by coumarin in the biofilm cells
(Supplementary Table S2), including several genes encoding
T3SS regulators (exsC, exsD, and ptrA). The c-di-GMP PDE
encoding gene PA4781 was downregulated in coumarin-treated
biofilm cells by 2-fold.
In addition, 234 genes were upregulated in the coumarin-
treated biofilm cells (Supplementary Table S3). PA2226
encoding a negative QS regulator QsrO was upregulated by
3.7-fold. Overexpression of QsrO has been reported to repress
the las, rhl, and PQS systems of P. aeruginosa, although the
detailed mechanisms have not been elucidated yet (Köhler
et al., 2014). Co-expression of PA2226 and PA2225 prevents
the induction of T3SS (Köhler et al., 2014), and PA2225 was
found to be upregulated by 2.0-fold in the coumarin-treated
biofilm. tpbA, encoding a tyrosine phosphatase that represses
c-di-GMP production (Ueda and Wood, 2009) was upregulated
by 4.0-fold in the coumarin-treated biofilm cells. No significant
changes in the expression of other diguanylate cyclase (DGC)
or PDE genes involved in c-di-GMP metabolism were found in
coumarin-treated biofilm cells.
Coumarin Reduced C-di-GMP Level in
P. aeruginosa
To confirm the influence of coumarin on c-di-GMP metabolism,
we determined intracellular c-di-GMP concentrations of
planktonic P. aeruginosa cells. As shown in Figure 5A, the
c-di-GMP concentration in the untreated PAO1 control was
2.89 ± 0.21 pmol/mg of wet cells, while the intracellular
c-di-GMP level in PAO1 treated with 2 mM coumarin was
significantly reduced (p < 0.05) to 1.37 ± 0.13 pmol/mg
of wet cells. When treated with 2 mM coumarin, the c-di-
GMP concentration in the five clinical P. aeruginosa strains
investigated, was reduced by 36.4∼69.7% compared to the
untreated control (Figure 5B).
DISCUSSION
Coumarin was previously described as a QSI in P. aeruginosa
(Gutiérrez-Barranquero et al., 2015) and this was confirmed
in the present study. In addition, coumarin reduced protease
and pyocyanin production in different P. aeruginosa strains, as
well as biofilm formation both in microtiter plates and in an
in vitro wound model. We also demonstrated that coumarin
increases the survival of L. sericata maggots in the presence of
P. aeruginosa PAO1 and recent clinical strains. A transcriptomic
analysis demonstrated that the expression of a large number of
genes (including genes involved in QS and T3SS) is regulated
in response to coumarin in the biofilms of P. aeruginosa,
and intracellular c-di-GMP levels were lower in treated cells,
compared to untreated controls.
Several studies have shown that clinical P. aeruginosa
strains display varying levels of virulence, and highlighted the
importance to include clinical isolates when evaluating the
effect of potential novel treatment approaches (García-Contreras
et al., 2015; Guendouze et al., 2017). We observed that different
P. aeruginosa clinical isolates indeed vary significantly in their
ability to produce protease and pyocyanin, as well as in their
virulence towards L. sericata. Coumarin significantly inhibited
biofilm formation in microtiter plates for all P. aeruginosa
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FIGURE 5 | The effect of coumarin on c-di-GMP level in P. aeruginosa. (A) C-di-GMP level of P. aeruginosa PAO1 treated with different concentrations of coumarin.
(B) C-di-GMP level in different P. aeruginosa clinical strains treated with 2 mM coumarin. ∗p < 0.05 compared to the untreated control in one-way ANOVA or
Kruskal–Wallis test. Data shown are the mean (n = 3), error bars represent standard deviation.
strains tested, whereas its biofilm-inhibitory effect in the wound
model and its effect on virulence in L. sericata were strain-
dependent, suggesting that coumarin’s effect as QSI is reduced in
the more complex in vivo environment and that the therapeutic
role of coumarin in treating wound infections and helping
with maggot-based debridement therapy may be limited. The
strain-dependent effects in clinical P. aeruginosa isolates have
also been reported for other QS inhibition agents, such as
furanone C-30 (García-Contreras et al., 2015), 5-fluorouracil
(García-Contreras et al., 2013), ZnO nanoparticles (García-
Lara et al., 2015), and the quorum quenching enzyme SsoPox
(Guendouze et al., 2017). Combined, these data indicate that
in many cases QSI are less effective in clinical strains and
whether these QSI can be developed into effective anti-virulence
drugs remains to be determined (which will require more
data in animal models and on a larger number of clinical
strains).
To obtain a global picture of effect of coumarin on QS, biofilm,
and virulence of P. aeruginosa, we performed transcriptome
analysis on P. aeruginosa PAO1 planktonic cells after 1 h
of treatment with coumarin, as well as on biofilms treated
with coumarin for 24 h. The expression of genes involved in
the QS system of P. aeruginosa was not significantly changed
in planktonic cells after 1 h. In a previous study, coumarin
(1.36 mM) has been reported to reduce the expression of pqsA
and rhlI in planktonic cells after 6 h and 24 h, respectively, while
lasI expression was not affected either at 6 h or 24 h (Gutiérrez-
Barranquero et al., 2015). In biofilm cells we found that lasI
expression was downregulated by coumarin, as well as rhlI, rhlR,
and genes within the pqsABCDE and ambBCDE operons. These
results confirm that coumarin interferes with the P. aeruginosa
QS network. The observation that the expression of QS-regulated
virulence genes was downregulated in P. aeruginosa PAO1 was in
line with the decreased protease and pyocyanin production and
reduced virulence observed in L. sericata. Also qsrO, encoding
a negative regulator of QS was overexpressed in coumarin-
treated biofilms suggesting that this regulator contributes to the
inhibition of QS by coumarin.
T3SS acts as a major virulence determinant in P. aeruginosa
that manipulates host cell responses and plays an important role
in acute infections (Hauser, 2009). A microarray-based analysis
of P. aeruginosa QS regulons revealed that at least three genes
involved in T3SS (pscQ, pscI, and pcrH) are negatively regulated
by QS (Wagner et al., 2003). Bleves et al. (2005) have also
reported that the expression of T3SS in P. aeruginosa is negatively
regulated by QS, especially by RhlR under low calcium levels.
These results raise the concern that interfering with QS might
potentially increase the T3SS-related virulence in P. aeruginosa
(García-Contreras, 2016). However, transcriptome data obtained
from P. aeruginosa treated with coumarin in the present study
and 6-gingerol, another QSI (Kim et al., 2015) revealed that
genes involved in T3SS were repressed. These results suggest
that although QS has been reported to negatively affect T3SS
expression, QS inhibition by certain QSIs may not necessarily
induce T3SS-related virulence. In contrast, it is possible to inhibit
QS and T3SS simultaneously by QSIs such as coumarin and
6-gingerol, although the underlying mechanisms remain to be
elucidated.
C-di-GMP regulates many bacterial behaviors, and a high
intracellular c-di-GMP concentration has been reported to
promote biofilm formation in P. aeruginosa and other bacteria
(Römling et al., 2013). The intracellular concentration of c-di-
GMP is determined by GGDEF domain-containing DGCs (which
synthesize c-di-GMP), and EAL or HD-GYP domain-containing
PDEs (which degrade c-di-GMP) (Römling et al., 2013). We
found that coumarin affected two genes involved in c-di-GMP
metabolism in P. aeruginosa PAO1, i.e., PA4781 and tpbA,
and demonstrated that coumarin significantly reduced the c-di-
GMP level in P. aeruginosa. We hypothesize this is due to
the upregulation of tpbA. TpbA acts as a negative regulator of
c-di-GMP production, which deactivates the GGDEF-domain
DGC TpbB responsible for c-di-GMP synthesis and indirectly
reduces c-di-GMP levels in P. aeruginosa (Ueda and Wood,
2009). This effect is apparently stronger than the consequence
of downregulation of PA4781, what on itself would result in
increased c-di-GMP levels.
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Our results indicate that coumarin not only acts as a QSI but
also reduces c-di-GMP levels, and these combined effects may
explain the reduced biofilm formation observed. The connections
between QS and c-di-GMP in P. aeruginosa have just begun to
be elucidated. Mutants of P. aeruginosa PA14 without functional
lasI, lasR, or rhlR showed decreased expression of tpbA (Ueda
and Wood, 2009), leading to the assumption that QS negatively
regulates c-di-GMP levels through TpbA/TpbB. However, our
results showed that coumarin inhibits QS-related genes, but the
expression of tpbA was significantly upregulated by coumarin and
led to reduced c-di-GMP level. Another study showed that rhl
and PQS systems were expressed at a higher level in P. aeruginosa
PAO1 with reduced c-di-GMP level due to overexpression of
yhjH (encoding a PDE) than in a wspF mutant with elevated
c-di-GMP levels (Lin Chua et al., 2017). This suggested that low
c-di-GMP levels could increase expression of QS-related genes
and the production of QS-regulated virulence factors. In contrast,
our results showed that coumarin reduced both c-di-GMP levels
and QS-regulated virulence. These results might be explained by
the different mechanisms leading to the reduced c-di-GMP level.
The distinct gene expression profiles (431 upregulated genes and
595 downregulated genes) observed in the study of Lin Chua et al.
is directly due to the loss of wspF and overexpression of yhjH,
whereas in our study no change was observed in wspF expression.
Several other compounds of the coumarin class have also
been reported for their anti-QS and anti-biofilm effects, e.g.,
esculetin, esculin, and umbelliferone (Zeng et al., 2008; Lee et al.,
2014). Our research on the prototype coumarin molecule in this
family revealed that coumarin can inhibit not only QS but also
T3SS and c-di-GMP signaling, leading to reduced virulence and
biofilm formation in P. aeruginosa. These results increase our
understanding of the molecular mechanism(s) involved in the
activity of coumarin and related molecules, and suggest these
molecules could be useful to combat biofilm-related infections.
Although the effects of coumarin in inhibiting P. aeruginosa
biofilm formation in a wound model and virulence to L. sericata
were found to be strain-dependent, structural modifications
based on the coumarin scaffold may allow the development of
more active coumarin-derivatives with potential application in
the treatment of P. aeruginosa infections.
CONCLUSIONr Coumarin can reduce QS-regulated virulence and biofilm
formation in P. aeruginosa strains, but its effect on
P. aeruginosa biofilm formed in wound model and the
virulence to L. sericata maggots is strain-dependent.r Coumarin downregulates the expression of key genes
involved in the las, rhl, PQS, and IQS systems in the biofilm
of P. aeruginosa.r Coumarin reduces the expression of genes related to type
III secretion, and decreases the cellular c-di-GMP level in
P. aeruginosa.
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